CooperCompanies to Participate in the Wells Fargo Healthcare Conference
CooperCompanies (Nasdaq: COO), a leading global medical device company, has announced its participation in the upcoming Wells Fargo Healthcare Conference. President and CEO Al White will represent the company in a session scheduled for September 3, 2025, at 3:00 PM ET.
Investors and interested parties can access the webcast through CooperCompanies' investor relations website at http://investor.coopercos.com.
CooperCompanies (Nasdaq: COO), azienda globale leader nel settore dei dispositivi medici, ha annunciato la sua partecipazione alla prossima Wells Fargo Healthcare Conference. Il presidente e CEO Al White rappresenterà la società in una sessione programmata per il 3 settembre 2025 alle 15:00 ET.
Investitori e altri interessati possono seguire la webcast tramite il sito delle relazioni con gli investitori di CooperCompanies all'indirizzo http://investor.coopercos.com.
CooperCompanies (Nasdaq: COO), una destacada empresa mundial de dispositivos médicos, ha anunciado su participación en la próxima Wells Fargo Healthcare Conference. El presidente y CEO Al White representará a la compañía en una sesión programada para el 3 de septiembre de 2025 a las 3:00 PM ET.
Los inversores y otras personas interesadas pueden acceder a la retransmisión por Internet a través del sitio web de relaciones con inversores de CooperCompanies en http://investor.coopercos.com.
CooperCompanies (Nasdaq: COO)는 글로벌 의료기기 선도 기업으로서 다가오는 Wells Fargo Healthcare Conference에 참가한다고 발표했습니다. 사장 겸 CEO 알 화이트(Al White)가 2025년 9월 3일 오후 3시(동부시간)에 예정된 세션에서 회사를 대표합니다.
투자자와 관심 있는 분들은 CooperCompanies의 투자자 관계 웹사이트(http://investor.coopercos.com)를 통해 웹캐스트에 접속할 수 있습니다.
CooperCompanies (Nasdaq: COO), entreprise mondiale de premier plan dans les dispositifs médicaux, a annoncé sa participation à la prochaine Wells Fargo Healthcare Conference. Le président et CEO Al White représentera la société lors d'une session prévue le 3 septembre 2025 à 15h00 (ET).
Les investisseurs et toute personne intéressée peuvent accéder au webcast via le site des relations investisseurs de CooperCompanies à l'adresse http://investor.coopercos.com.
CooperCompanies (Nasdaq: COO), ein weltweit führendes Unternehmen im Bereich Medizintechnik, hat seine Teilnahme an der bevorstehenden Wells Fargo Healthcare Conference angekündigt. Präsident und CEO Al White wird das Unternehmen in einer Sitzung vertreten, die für den 3. September 2025 um 15:00 Uhr ET angesetzt ist.
Investoren und Interessierte können das Webcast über die Investor-Relations-Website von CooperCompanies unter http://investor.coopercos.com aufrufen.
- None.
- None.
SAN RAMON, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the Wells Fargo Healthcare Conference on Wednesday, September 3, 2025. Al White, President and CEO, will represent the Company in a session scheduled at 3:00 PM ET.
The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com.
About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 16,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
